Biotech ETF Sees Upside; Related Names Higher (GILD) (CELG) (BIIB) (AMGN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
Regeneron Pharmaceuticals (REGN) Higher as Sanofi Raises Stake in 20.5%
July 1, 2014 10:30 AM EDTRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is 5.5% higher today after Sanofi (NYSE: SNY) disclosed in an amended 13D filing that it raised its stake to 20.5%, or 20,258,841 shares. The firm bought an aggregate of 240,751 shares of Common Stock in recent market transactions.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is supplemented as follows:
The Reporting Person has determined to purchase, directly or through its subsidiaries, additional shares of Common Stock to increase its beneficial ownership to... More
